Letter to editors

Till now, no treatment or vaccine has been characterized for COVID-19 [@b0005]. Angiotensin-Converting Enzyme-II (ACE-II) receptor, most likely the COVID-19 target, plays essential roles in virus transmission to the alveolar cells [@b0010]. Accordingly, agents with potential inhibition or regulation of ACE-II receptors might be effective in COVID-19 management [@b0015].

Bioactive compounds are valuable for drug development and adjuvant therapy of such infection. These compounds can act either as preventive agents or treatment accelerators. Naringin (a flavanone-7-O-glycoside with potential inhibition of COVID-19 binding to ACE-II receptors), Naringenin and Hesperetin (flavanone), Hesperidin (flavanone glycoside), Baicalin and Neohesperidin (flavone glycoside), Nobiletin (O-methylated flavone), Scutellarin (a flavone), Nicotinamine (nonproteinogenic amino acid), Glycyrrhizin (saponin) and Emodin (6-methyl-1,3, 8-trihydroxyanthraquinone) are of most considerable natural ACE-II inhibitors [@b0020], [@b0025], [@b0030].

The averting impact of Naringin on pro-inhibitory cytokines (increased in COVID-19 infection) including Cyclooxygenase-II, Interleukin-6 and -1β, and Nitric oxide synthase is considerable [@b0025]. Glycyrrhizin can inhibit COVID-19 S-protein binding to ACE-II receptors [@b0035]. Emodin, a bioactive antiviral agent may prevent S-protein binding to ACE-II receptors. Thus, Emodin and probably Aloe-emodin can stave off the COVID-19 infection via competing with S-protein in binding to ACE-II [@b0035]. *Rheum palmatum* L. and *Aloe vera* (L.) Burm.f. are rich sources of these compounds [@b0040].

Based on this opinion ([Fig. 1](#f0005){ref-type="fig"} ), concerned compounds could be applied in prevention and management of COVID-19 solely or combination with conventional interventions.Fig. 1Schematic view of bioactive compounds with ACE-II inhibitory activities.
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